Tag: US0956331039

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

ACTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced financial results for the quarter ended June 30, 2025, and provided an update on its Symphony IL-6 test program and key operational milestones.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsUS0956331039

DarkIris Inc. Announces Pricing of Initial Public Offering

Houston Native Mighty Bolton Drives ‘The Art of Dialogue’ to Global Success with Authentic Storytelling

DAESHIN MC Targets Singapore Market with Smart Cleaning Solutions at ‘BEX ASIA 2025’

Tag: US0956331039

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us